The study, titled "Enhancing Digital N-of-1 Trial: A Comprehensive Exploration of User and Clinician Engagement, Motivations, and Experiences in Ghana Using the StudyMe and StudyU Apps," focuses on exploring how digital tools can be used to design personalized trials.
Am 8. Mai 2024 präsentierte Johannes Vedder, leitender Entwickler von StudyU, die StudyU-Plattform auf dem 2. Frühjahrssymposium für Medizinische Informatik in Heidelberg, Deutschland.
The "Anti-Stress Intervention Among Physicians (ASIP)" Study utilizes StudyU to investigate the following intriguing and pertinent research question:
How can the everyday level of perceived stress be reduced in a fast and easy-to-implement manner?
The project will be conducted in cooperation with the Institute for Public Health at Charité – Universitätsmedizin Berlin (Principal Investigator: Dr. med. Valentin Vetter).
We are pleased to announce the publication of the first research paper utilizing the StudyU platform for a medical study. The paper Study protocol: combined N-of-1 trials to assess open-label placebo treatment for antidepressant discontinuation symptoms [FAB-study] was published in cooperation with Universitätsklinikum Hamburg-Eppendorf and Universitätsklinikum Giessen und Marburg, both of them based in Germany.
Let us have a deeper look into the content of this innovative study and what this achievement means for StudyU.
On June 8, 2023, we had the honor of introducing StudyU to Prof. Dr. Karl Lauterbach, the German Federal Minister of Health, during his visit to the Digital Health Cluster at the Hasso Plattner Institute (HPI).
StudyU has won the Best Idea Award 2022 of the School Of Entrepreneurship at Hasso Plattner Institute (HPI). The team consists of Pauline Gieseler and Johannes Vedder, who are both students at the Hasso Plattner Institute in Potsdam, Germany.
Winning this award grants us the opportunity to visit HPI New York City and meet its director, Dr. Joann Halpern. Additionally, it enables us to establish connections with HPI･MS, a collaborative project between HPI and Mount Sinai Health System, renowned as one of the world's top-ranked hospitals.